Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05142241
Title Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients >= 18 Years Old With Advanced Stage Rare Cancers, RARE 2 Study
Recruitment Recruiting
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Age Groups: senior | adult | child
Covered Countries USA

No variant requirements are available.